dyspepsia
DYSPEPSIA

Dyspepsia is having any one of the following: Disturbing postprandial fullness, early satiation, epigastric pain and/or burning felt predominantly in the upper abdomen.

It is considered a symptom complex rather than a specific diagnosis.

Acid suppression is the recommended initial therapy.

Definition

  • Refers to pain or discomfort centered in the upper abdomen
    • Discomfort refers to a subjective sensation that the patient does not interpret as pain which may be characterized by or associated with upper abdominal fullness, early satiety, bloating, belching, nausea and vomiting (N/V)
    • Centered refers to pain or discomfort in or around the midline
  • Dyspepsia is considered a symptom complex rather than a specific diagnosis

Signs and Symptoms

  • Ulcer-like
    • Chronic or recurrent epigastric pain or discomfort for at least 2-4 weeks
  • Reflux-like
    • Acid regurgitation
    • Heartburn
  • Dysmotility-like
    • Bloating in upper abdomen not accompanied by visible distension
    • Early satiety
    • N/V
    • Postprandial fullness
    • Upper abdominal discomfort often aggravated by food
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Gastroenterology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Audrey Abella, 16 Oct 2019
The PD-1* inhibitor nivolumab showed significant survival benefit and a favourable safety profile than taxane chemotherapy in patients with unresectable advanced or recurrent oesophageal squamous cell carcinoma (OSCC) refractory or intolerant to previous fluoropyrimidine- and platinum-based chemotherapy, according to the findings of ATTRACTION-3** presented at ESMO 2019.
03 Oct 2019
Early enteral nutrition (EEN) speeds up the recovery of gastrointestinal function after laparoscopic common bile duct exploration (LCBDE), according to a study. However, EEN also increases complications such as diarrhoea and abdominal distension.
01 Sep 2019
A third of Clostridium difficile infection (CDI) patients with cirrhosis have been readmitted in a span of 30 days primarily due to recurrent CDI, a recent study has found. In addition, there is a high rate of mortality linked to CDI in patients with cirrhosis, in which a poor prognosis is predicted by decompensation and 30-day readmission.
26 Sep 2019
Use of proton pump inhibitors contributes to increased risk of cholangitis, a large cohort study suggests.